PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Sep-2025 TME Pharma Completes August Financing and Publishes Cash Position Businesswire
01-Sep-2025 Global Digital Pathology Market to Grow at ~10.5% CAGR, Driven by Chronic Diseases by 2029 MediTech-Insights
01-Sep-2025 Global Neurodiagnostics Market to Grow at 7-8% CAGR, Driven by Neurological Disorders by 2028 MediTech-Insights
01-Sep-2025 Global Breast Imaging Market to Grow at 7-9% CAGR, Driven by Cancer Detection Focus by 2030 MediTech-Insights
01-Sep-2025 Global Laser Hair Removal Market to Grow at 17-19% CAGR, Driven by Aesthetic Demand by 2028 MediTech-Insights
01-Sep-2025 Global mHealth Solutions Market to Grow at ~25% CAGR, Boosted by Digital Health & Aging by 2028 MediTech-Insights
01-Sep-2025 Global Wearable Medical Devices Market to See Double-Digit Growth Driven by Tech & Health Trends by 2028 MediTech-Insights
01-Sep-2025 Global Bioanalytical Services Market to Witness Double-Digit Growth Fueled by R&D by 2027 MediTech-Insights
01-Sep-2025 Global Medical Device Security Market to Grow at 8-10% CAGR, Driven by Cyber Threats by 2027 MediTech-Insights
01-Sep-2025 Global Healthcare RCM Market to Grow at ~11-12% CAGR, Driven by Cloud & Workflow Optimization by 2027 MediTech-Insights
01-Sep-2025 Global Medical Display Market to Grow at 5% CAGR, Driven by MIT & Tech Advancements by 2027 MediTech-Insights
01-Sep-2025 Pharma Contract Manufacturing is the Quiet Reshoring Engine Investors Can’t Ignore ACCESS Newswire
01-Sep-2025 CEO transition at SKAN Group: Jonas Greutert to succeed Thomas Huber effective January 1, 2026 SKAN AG
01-Sep-2025 AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network – Revenue increased by more than 20% in the first half of 2025 despite challenging conditions AEVIS VICTORIA SA
31-Aug-2025 AI Clinical Documentation Adoption Surges, but ROI Hinges on Governance ACCESS Newswire
31-Aug-2025 Could DEA Be Next? EPA Firings Spark Questions About DEA's Accountability in MMJ's Marijuana Licensing Delays ACCESS Newswire
30-Aug-2025 Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension Businesswire
30-Aug-2025 Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction Businesswire
30-Aug-2025 Nutriessential Celebrates 20 Years of Excellence in Premium, GMP-Certified Supplements - Expands Global Reach ACCESS Newswire
29-Aug-2025 Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Businesswire